Delayed asthmatic response to bronchial challenge with allergen-mediators, eicosanoids, eosinophil and neutrophil constituents in the blood and urine

Respiration

Volumn 82, Issue 3, 2011, Pages 225-236

  Pelikan, Zdenek ^a  

^a Allergy Research Foundation   (Netherlands)

Author keywords

Bronchial provocation tests with allergen; Delayed asthmatic response; Eicosanoids; Eosinophil constituents; Neutrophil constituents

Indexed keywords

11 EPIPROSTAGLANDIN F2 ALPHA; ALLERGEN; CELL PROTEIN; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHIL PEROXIDASE; EOSINOPHIL PROTEIN X; HISTAMINE; ICOSANOID; LEUKOTRIENE B4; LEUKOTRIENE C4; LEUKOTRIENE E4; LIPOXIN A; MYELOPEROXIDASE; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; THROMBOXANE B2; TRYPTASE;

ADULT; ALLERGIC ASTHMA; ARTICLE; CONTROLLED STUDY; DELAYED ASTHMATIC RESPONSE; DELAYED HYPERSENSITIVITY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FATTY ACID BLOOD LEVEL; FEMALE; HISTAMINE BLOOD LEVEL; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTAGLANDIN BLOOD LEVEL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; PROVOCATION TEST; SKIN TEST; URINE LEVEL;

ADULT; ALLERGENS; ASTHMA; BRONCHIAL PROVOCATION TESTS; EICOSANOIDS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHILS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; HYPERSENSITIVITY, DELAYED; MALE; MIDDLE AGED; NEUTROPHILS;

EID: 80051782637     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000324542     Document Type: Article

References (68)

1. Busse WW, O'Byrne PM, Holgate ST: Asthma pathogenesis; in Adkinson NF, Yunginger JW, Busse WW, Bochner BS, Holgate ST, Simons FER (eds): Middleton's Allergy, Principles and Practice, ed 6. St Louis, Mosby, 2003, pp 1175-1207.
2. Christodoulopoulos P, Tulic MK, Kontolemas M, Hamid Q: Immunopathology of allergic airway inflammation; in Adkinson NF, Yunginger JW, Busse WW, Bochner BS, Holgate ST, Simons FER (eds): Middletons's Allergy, Principles and Practice, ed 6. St Louis, Mosby, 2003, pp 501-514.
3. Holgate ST, Lemanske RF, O'Byrne PM, Kakumanu S, Busse WW: Asthma pathogenesis; in Adkinson NF, Bochner BS, Busse WW, Holgate ST, Lemanske RF, Simons FE (eds): Middleton's Allergy, Principles and Practice, ed 7. Philadelphia, Elsevier, 2009, pp 893- 919.
4. Pelikan Z, Pelikan-Filipek M, Kruis M, Berger MPF: The immediate asthmatic response to allergen challenge. Ann Allergy 1986; 56: 252-260. (Pubitemid 16135686)
5. Pelikan Z, Pelikan-Filipek M: The late asthmatic response to allergen challenge - part I and II. Ann Allergy 1986; 56: 414-435.
6. Pelikan Z, Pelikan-Filipek M, Oostenbrink JH: Delayed asthmatic response (DYAR), its clinical feature and pharmacologic modulation (abstract 1313). J Allergy Clin Immunol 1997; 99: 321.
7. Pelikan Z: Delayed type of asthmatic response to allergen challenge. 1. Clinical features. Ann Allergy Asthma Immunol 2010; 104: 394-404.
8. Wenzel SE, Westcott JY, Larsen GL: Bronchoalveolar lavage fluid mediator levels 5 min after allergen challenge in atopic subjects with asthma: Relationship to the development of late asthmatic response. J Allergy Clin Immunol 1991; 87: 540-548.
9. Fahy JV: Eosinophilic and neutrophilic inflammation in asthma. Proc Am Thorac Soc 2009; 6: 256-259.
10. Jarjour NN, Calhoun WJ, Kelly EA, Gleich GJ, Schwartz LB, Busse WW: The immediate and late allergic response to segmental bronchopulmonary provocation in asthma. Am J Respir Crit Care Med 1997; 155: 1515-1521. (Pubitemid 27216652)
11. Green RH, Brightling CE, Bradding P: The reclassification of asthma based on subphenotypes. Curr Opin Allergy Clin Immunol 2007; 7: 43-50. (Pubitemid 46095885)
12. Simpson JL, Scott R, Boyle MJ, Gibson PG: Inflammatory subtypes in asthma: Assessment and identification using induced sputum. Respirology 2006; 11: 54-61.
13. Douwes J, Gibson P, Pekkanen J, Pearce N: Non-eosinophilic asthma: Importance and possible mechanisms. Thorax 2002; 57: 643-648. (Pubitemid 34761769)
14. Sedgwick JB, Vrtis RF, Jansen KJ, Kita H, Bartemes K, Busse WW: Peripheral blood eosinophils from patients with allergic asthma contain increased intracellular eosinophil- derived neurotoxin. J Allergy Clin Immunol 2004; 114: 568-574. (Pubitemid 39194930)
15. Frew AJ, St-Pierre J, Teran LM, Trefilieff A, Madden J, Peroni D, Bodey KM, Walls AF, Howarth PH, Carroll MP, Holgate ST: Cellular and mediator responses twenty-four hours after local endobronchial allergen challenge of asthmatic airways. J Allergy Clin Immunol 1996; 98: 133-143. (Pubitemid 26289395)
16. Bancalari L, Dente FL, Cianchetti S, Prontera C, Taccola M, Bacci E, Carletti A, Di Franco A, Giannini D, Vagaggini B, Ferdeghini M, Paggiaro PL: Blood markers of early and late airway responses to allergen in asthmatic subjects. Relationship with functional findings. Allergy 1997; 52: 32-40. (Pubitemid 27120623)
17. Huang TJ, MacAry PA, Eynott P, Moussavi A, Daniel KC, Askenase PW, Kemeny DM, Chung KF: Allergen-specific Th1 cells counteract efferent Th2 cell-dependent bronchial hyperresponsiveness and eosinophilic inflammation partly via IFN-γ. J Immunol 2001; 166: 207-217. (Pubitemid 32038434)
18. Shindo K, Koide K, Fukumura M: Plateletactivating factor increases leukotriene B 4 release in stimulated alveolar macrophages from asthmatic patients. Eur Respir J 1996; 11: 1098-1104.
19. Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF, Barnes PJ: Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 1999; 160: 1532-1539.
20. Liu MC, Proud D, Lichtenstein LM, Hubbard WC, Bochner BS, Stealey BA, Breslin L, Xiao H, Freidhoff LR, Schroeder JT, Schleimer RP: Effects of prednisolone on the cellular responses and release of cytokines and mediators after segmental allergen challenge in asthmatic subjects. J Allergy Clin Immunol 2001; 108: 29-38. (Pubitemid 32662229)
21. Diaz P, Gonzales MC, Galleguillos FR, Ancic P, Cromwell O, Shepherd D, Durham SR, Gleich GJ, Kay AB: Leukocyte and mediators in bronchoalveolar lavage during allergeninduced late-phase asthmatic reactions. Am Rev Respir Dis 1989; 139: 1383-1389. (Pubitemid 19155494)
22. MacFarlane AJ, Dworski R, Sheller JR, Pavord ID, Kay AB, Barnes NC: Sputum cysteinyl leukotrienes increase 24 h after allergen inhalation in atopic asthmatics. Am J Respir Crit Care Med 2000; 161: 1553-1558. (Pubitemid 30329026)
23. Manning PJ, Rokach J, Malo JL, Ethier D, Cartier A, Girard Y, Charleson S, O'Byrne PM: Urinary leukotriene E 4 levels during early and late asthmatic responses. J Allergy Clin Immunol 1990; 86: 211-220. (Pubitemid 20288726)
24. O'Sullivan S, Roquet A, Dahlen B, Dahlen S, Kumlin M: Urinary excretion of inflammatory mediators during allergen-induced early and late phase asthmatic reactions. Clin Exp Allergy 1998; 28: 1332-1339. (Pubitemid 28559006)
25. Pelikan Z: The concentrations of histamine (HS) in the blood and their changes during basic types of asthmatic response (immediate = IAR; late = LAR; delayed = DYAR) to allergen challenge (abstract P356). Allergy 1996; 51(suppl 310):112.
26. Berry M, Morgan A, Shaw DE, Parker D, Green R, Brightling C, Bradding P, Wardlaw AJ, Pavord ID: Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma. Thorax 2007; 62: 1043-1049. (Pubitemid 350206195)
27. Haldar P, Pavord ID: Noneosinophilic asthma: A distinct clinical and pathologic phenotype. J Allergy Clin Immunol 2007; 119: 1043-1052. (Pubitemid 46654194)
28. Fahy JV, Liu J, Wong H, Boushey HA: Analysis of cellular and biochemical constituents of induced sputum after allergen challenge: A method for studying allergic airway inflammation. J Allergy Clin Immunol 1994; 93: 1031-1039. (Pubitemid 24187956)
29. Fiorini G, Crespi S, Rinaldi M, Oberti E, Vigorelli P, Palmieri G: Serum ECP and MPO are increased during exacerbations of chronic bronchitis with airway obstruction. Biomed Pharmacother 2000; 54: 274-278. (Pubitemid 30432097)
30. Bochenek G, Nagraba K, Nizankowska E, Szczeklik A: A controlled study of 9 α ,11 β - PGF 2 (a prostaglandin D 2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge. J Allergy Clin Immunol 2003; 111: 743-749. (Pubitemid 36470243)
31. Barck Ch, Lundahl J, Hallden G, Bylin G: Total eosinophil cationic protein levels in induced sputum as a marker of changes in eosinophilic inflammation in a patient with allergic asthma. Ann Allergy Asthma Immunol 2005; 95: 86-92. (Pubitemid 41022778)
32. Kumlin M, Dahlen B, Bjorck T, Zetterström O, Granström E, Dahlen SE: Urinary excretion of leukotriene E 4 and 11-dehydrothromboxane B 2 in response to bronchial provocations with allergen, aspirin, leukotriene D 4 , and histamine in asthmatics. Am Rev Respir Dis 1992; 146: 96-103.
33. Theron AJ, Gravett CM, Steel HC, Tintinger GR, Feldman C, Anderson R: Leukotrienes C 4 and D 4 sensitize human neutrophils for hyperreactivity to chemoattractants. Inflam Res 2009; 58: 263-268.
34. Nagata M, Saito K, Tsuchiya K, Sakamoto Y: Leukotriene D 4 upregulates eosinophil adhesion via cysteinyl leukotriene 1 receptor. J Allergy Clin Immunol 2002; 109: 676-680. (Pubitemid 34327196)
35. Sampson AP, Castling DP, Green CP, Price JF: Persistent increase in plasma and urinary leukotrienes after acute asthma. Arch Dis Child 1995; 73: 221-225.
36. Bhavsar PK, Levy BD, Hew MJ, Pfeffer MA, Kazani S, Israel E, Chung KF: Corticosteroid suppression of lipoxin A 4 and leukotriene B 4 from alveolar macrophages in severe asthma. Respir Res 2019; 11: 71-80.
37. Kostikas K, Gaga M, Papatheodorou G, Karamanis T, Orphanidou D, Loukides S: Leukotriene B 4 in exhaled breath condensate and sputum supernatant in patients with COPD and asthma. Chest 2005; 127: 1553-1559. (Pubitemid 46218778)
38. Monteseirin J, Bonilla I, Camacho J, Conde J, Sobrino F: Elevated secretion of myeloperoxidase by neutrophils from asthmatic patients: The effect of immunotherapy. J Allergy Clin Immunol 2001; 107: 623-626. (Pubitemid 32397748)
39. Plötz SG, Traidl-Hoffmann C, Feussner I, Kasche A, Feser A, Ring J, Jakob T, Behrendt H: Chemotaxis and activation of human peripheral blood eosinophils induced by pollen- associated lipid mediators. J Allergy Clin Immunol 2004; 113: 1152-1160. (Pubitemid 38857999)
40. Levy BD, Bonnans C, Silverman ES, Palmer LJ, Marigowda G, Israel E: Diminished lipoxin biosynthesis in severe asthma. Am J Respir Crit Care Med 2005; 172: 824-830. (Pubitemid 41369064)
41. 4) in asthmatic patients during attack and remission. Arerugi 1994; 43: 28-36.
42. Wenzel SE, Westcott JY, Smith HR, Larsen GL: Spectrum of prostanoid release after bronchoalveolar allergen challenge in atopic asthmatics and in control groups. An alteration in the ratio of bronchoconstrictive to bronchoprotective mediators. Am Rev Respir Dis 1989; 139: 450-457. (Pubitemid 19057424)
43. Seymour ML, Rak S, Aberg D, Riise GC, Penrose JF, Kanaoka Y, Austen KF, Holgate ST, Sampson AP: Leukotriene and prostanoid pathway enzymes in bronchial biopsies of seasonal allergic asthmatics. Am J Respir Crit Care Med 2001; 164: 2051-2056. (Pubitemid 34023580)
44. Melillo G, Bonini S, Cocco G, Davies RJ, de Monchy JG, Frolund L, Pelikan Z: Provocation tests with allergens. Allergy 1997; 52 (suppl 35):5-36.
45. Siraganian RP: Histamine release and assay methods for the study of human allergy; in Rose NR, Friedman H, Fahey JL (eds): Manual of Clinical Laboratory Immunology, ed 3. Washington, American Society of Microbiology, 1986, pp 675-684.
46. Houd DJ, Taylor CC: Multivariate Analysis of Variance and Repeated Measures. London, Chapman and Hall, 1987.
47. Brightling CE, Ward R, Woltmann G, Bradding P, Sheller JR, Dworski R, Pavord ID: Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma. Am J Respir Crit Care Med 2000; 162: 878-882.
48. Ogawa Y, Calhoun WJ: The role of leukotrienes in airway inflammation. J Allergy Clin Immunol 2006; 118: 789-798. (Pubitemid 44498776)
49. Mondino C, Ciabattoni G, Koch P, Pistelli R, Trove A, Barnes PJ, Montushi P: Effects of inhaled corticosteroids on exhaled leukotrienes and prostanoids in asthmatic children. J Allergy Clin Immunol 2004; 114: 761-767. (Pubitemid 39330244)
50. Schmekel B, Karlsson SE, Linden M, Sundström C, Tegner H, Venge P: Myeloperoxidase in human lung lavage. A marker of local neutrophil activity. Inflammation 1990; 14: 447-454. (Pubitemid 20206257)
51. Motojima S, Akutsu I, Fukuda T, Makino S, Takatsu K: Clinical significance of measuring levels of sputum and serum ECP and serum IL-5 in bronchial asthma. Allergy 1993; 48: 98-1006.
52. Niggelmann B, Kleinau I, Schmitt M, Wahn U: Twenty-four-hour time course of eosinophil granule proteins ECP and EPX during bronchial allergen challenges in serum of asthmatic children. Allergy 1994; 49: 74-80. (Pubitemid 24051109)
53. Wenzel SE, Larsen GL, Johnston K, Voelkel NF, Westcott JY: Elevated levels of leukotriene C 4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge. Am Rev Respir Dis 1990; 142: 112-119. (Pubitemid 20224588)
54. Murray J, Tonnel A, Brash A, Roberts LJ, Gosset P, Workman R, Capron A, Oates JA: Release of prostaglandin D 2 into human airways during acute antigen challenge. N Engl J Med 1986; 315: 800-804. (Pubitemid 16014343)
55. Ying S, O'Connor BJ, Meng Q, Woodman N, Greenaway S, Wong H, Mallett K, Lee TH, Corrigan C: Expression of prostaglandin E 2 receptor subtypes on cells in sputum from patients with asthma and controls: Effect of allergen inhalational challenge. J Allergy Clin Immunol 2004; 114: 1309-1316. (Pubitemid 39575883)
56. Brussino L, Badiu I, Sciascia S, Bugiani M, Hffler E, Guida G, Malinovschi A, Bucca C, Rolla G: Oxidative stress and airway inflammation after allergen challenge evaluated by exhaled breath condensate analysis. Clin Exp Allergy 2010; 40: 1642-1647.
57. Taylor GW, Taylor I, Black P, Maltby NH, Turner N, Fuller RW, Dollery CT: Urinary leukotriene E 4 after antigen challenge and in acute asthma and allergic rhinitis. Lancet 1989;i:584-588. (Pubitemid 19074005)
58. Baraldi E, Carraro S, Alinovi R, Pesci A, Ghiro L, Bodini A, Piacentini G, Zacchello F, Zanconato S: Cysteinyl leukotrienes and 8-isoprostane in exhaled breath condensate of children with asthma exacerbations. Thorax 2003; 58: 505-509. (Pubitemid 36714012)
59. Haselden MB, Kay AB, Larche M: Immunoglobulin E-independent major histocompability complex-restricted T cell peptide epitope- induced late asthmatic reactions. J Exp Med 1999; 189: 1885-1894. (Pubitemid 29295887)
60. Jones MG, Floyd A, Nouri-Aria KT, Jacobson MR, Durham SR, Taylor AN, Cullinan P: Is occupational asthma to diisocyanates a non- IgE-mediated disease? J Allergy Clin Immunol 2006; 117: 663-669. (Pubitemid 43340233)
61. Bartoli ML, Di Franco A, Vagaggini B, Bacci E, Cianchetti S, Dente FL, Tonelli M, Paggiaro PL: Biological markers in induced sputum of patients with different phenotypes of chronic airway obstruction. Respiration 2009; 77: 265-272.
62. Simpson JL, McElduff P, Gibson PG: Assessment and reproducibility of non-eosinophilic asthma using induced sputum. Respiration 2010; 79: 147-151.
63. Gibson PG, Simpson JL, Saltos N: Heterogeneity of airway inflammation in persistent asthma: Evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest 2001; 119: 1329-1336. (Pubitemid 32686012)
64. Drews AC, Pizzichini MM, Pizzichini E, Pereira MU, Pitrez PM, Jones MH, Sly PD, Stein R: Neutrophilic airway inflammation is a main feature of induced sputum in nonatopic asthmatic children. Allergy 2009; 64: 1597-1601.
65. Baines KJ, Simpson JL, Scott RJ, Gibson PG: Immune responses of airway neutrophils are impaired in asthma. Exp Lung Res 2009; 35: 554-569.
66. Simpson JL, Scott RJ, Boyle MJ, Gibson PG: Differential proteolytic enzyme activity in eosinophilic and neutrophilic asthma. Am J Respir Crit Care Med 2005; 172: 559-565. (Pubitemid 41232966)
67. Baines KJ, Simpson JL, Bowden NA, Scott RJ, Gibson PG: Differential gene expression and cytokine production from neutrophils in asthma phenotypes. Eur Respir J 2010; 35: 522-531.
68. Pelikan Z: Delayed asthmatic response: A new phenotype of bronchial response to allergen challenge and soluble adhesion molecules in the serum. Ann Allergy Asthma Immunol 2011; 106: 119-130.